Motley Fool Asset Management LLC Ultragenyx Pharmaceutical Inc. Transaction History
Motley Fool Asset Management LLC
- $1.66 Billion
- Q3 2024
A detailed history of Motley Fool Asset Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 141,649 shares of RARE stock, worth $6.2 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
141,649
Previous 141,289
0.25%
Holding current value
$6.2 Million
Previous $5.81 Million
35.51%
% of portfolio
0.47%
Previous 0.4%
Shares
20 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$435 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$245 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$224 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$182 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$134 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.06B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...